Bristol-Myers Squibb CEO Giovanni Caforio told CNBC’s Jim Cramer on Monday why the pharmaceutical company paid a premium for heart drugs company MyoKardia.
Bristol Myers announced earlier that day i… [+1835 chars]
Bristol-Myers gets potentially revolutionary medicine in MyoKardia deal, CEO says – CNBC
